These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 10897662

  • 1. [Mechanism of progression of chronic renal failure and new treatment strategies].
    Litwin M.
    Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
    [Abstract] [Full Text] [Related]

  • 2. Endothelin receptor selectivity in chronic renal failure.
    Longaretti L, Benigni A.
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():32-7. PubMed ID: 19335745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Renoprotective effects of antihypertensives].
    Monhart V.
    Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P.
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progression to renal failure.
    Topaloğlu R.
    Turk J Pediatr; 2005 Feb; 47 Suppl():3-8. PubMed ID: 15884660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M.
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
    [Abstract] [Full Text] [Related]

  • 14. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M, van der Giet M, Zidek W.
    MMW Fortschr Med; 2000 Jun 22; 142(25):42-4. PubMed ID: 10920669
    [Abstract] [Full Text] [Related]

  • 15. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Bakris GL, Weir MR.
    Postgrad Med; 2008 Apr 22; 120(1):33-42. PubMed ID: 18467807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.